BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Civibrief//Brief deadlines//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Reproductive Health deadlines · Civibrief
BEGIN:VEVENT
UID:act-frl-2026-20613:comments-close@civibrief.com
DTSTAMP:20261114T182700Z
DTSTART;VALUE=DATE:20261207
SUMMARY:Comments close: Clinical Laboratory Improvement Amendments of 1988
  (CLIA); Virtual Access\, Gynecologic Cytology Proficiency Testing (PT)\,
  Personnel Qualifications\, and Other Changes
DESCRIPTION:This proposed rule would amend the Clinical Laboratory Improve
 ment Amendments of 1988 (CLIA) regulations to allow for virtual access un
 der the CLIA certificate of the primary testing laboratory that generated
  the data\, with the exception of the subspecialty of cytology\, and the 
 use of digital images for gynecologic cytology proficiency testing. This 
 proposed rule also includes proposed changes to personnel qualification r
 equirements and other proposed changes pertaining to SARS-CoV-2 reporting
  requirements\, certificate requirements\, test reporting requirements\, 
 enforcement requirements\, public consultation requirements\, and editori
 al and technical updates. These proposed updates aim to strengthen the Fe
 deral oversight of clinical laboratories and ensure accurate and reliable
  patient test results while adapting to modern technological capabilities
  and industry needs\, including workforce shortages.\nComment: http://www
 .regulations.gov/commenton/CMS-2026-3235-0001\nRecord: https://civibrief.
 com/actions/frl-2026-20613
URL:https://civibrief.com/actions/frl-2026-20613
END:VEVENT
BEGIN:VEVENT
UID:act-frl-2026-22306:effective@civibrief.com
DTSTAMP:20261114T182700Z
DTSTART;VALUE=DATE:20270104
SUMMARY:Takes effect: Improving Transparency Into Pharmacy Benefit Manager
  Fee Disclosure
DESCRIPTION:The Department is issuing a final regulation that will require
  providers of pharmacy benefit management services and affiliated provide
 rs of brokerage and consulting services to disclose information about the
 ir compensation to fiduciaries of large\, self-insured group health plans
  subject to the Employee Retirement Income Security Act (ERISA). Pharmacy
  spending is a major driver of overall healthcare costs for employers and
  is growing faster than medical and surgical spending. These disclosure r
 equirements apply for purposes of ERISA's statutory prohibited transactio
 n exemption for service arrangements under section 408(b)(2). These discl
 osures are needed so that fiduciaries can assess the reasonableness of co
 ntracts or arrangements with these service providers\, including the reas
 onableness of the service providers' compensation. As directed in section
  12 of President Trump's Executive Order 14273\, Lowering Drug Prices by 
 Once Again Putting Americans First\, the Department is issuing this rule 
 to improve employer health plan transparency into the direct and indirect
  compensation received by pharmacy benefit managers. This final rule will
  affect sponsors and other fiduciaries of large\, self-insured group heal
 th plans and certain service providers to such plans.\nRecord: https://ci
 vibrief.com/actions/frl-2026-22306
URL:https://civibrief.com/actions/frl-2026-22306
END:VEVENT
BEGIN:VEVENT
UID:act-frl-2026-22812:comments-close@civibrief.com
DTSTAMP:20261114T182700Z
DTSTART;VALUE=DATE:20270111
SUMMARY:Comments close: Medicare and Medicaid Programs; Cutting Administra
 tive Requirements for Excellence in Patient Care
DESCRIPTION:This proposed rule would reform Medicare and Medicaid regulati
 ons deemed obsolete or excessively burdensome on healthcare providers and
  suppliers\, with the objective of reducing costs\, enhancing flexibility
  in delivering innovative care\, and streamlining existing regulations. T
 his reform seeks to enable healthcare professionals to devote more resour
 ces to improving patient care by eliminating or minimizing requirements t
 hat impede quality patient care or that divert resources away from furnis
 hing high quality patient care.\nComment: http://www.regulations.gov/comm
 enton/CMS-2026-3631-0001\nRecord: https://civibrief.com/actions/frl-2026-
 22812
URL:https://civibrief.com/actions/frl-2026-22812
END:VEVENT
END:VCALENDAR